Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02502708
Title Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Primary Malignant Brain Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors NewLink Genetics Corporation
Age Groups: child | adult
Covered Countries USA

No variant requirements are available.